NHS Framework Agreement for the Supply of Human Normal Immunoglobulin (Panzyga)
The NHS Commissioning Board (operating under the name of NHS England)contractFind a Tender ↗Ref ocds-h6vhtk-02baf332014L0024active
Estimated value
—
goods
Awarded value
—
Suppliers
1
Lots
1
1 awarded
Published
11 Jun 2021
Description
NHS Framework Agreement for the Supply of Human Normal Immunoglobulin (Panzyga). The framework will commence on 1 June 2021 for a period of 7 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 6 months. Total maximum framework agreement including extension options will be no more than 13 months.
Scope
- Reference
- CM/PHS/21/5642
- Commercial tool
- Standalone contract
- Main category
- goods
- CPV classifications
- 33651520
- Contract locations
- North East EnglandNorth West EnglandYorkshire and the HumberEast MidlandsWest MidlandsEast of EnglandLondonSouth East EnglandSouth West EnglandScotlandNorthern Ireland
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| — | — | price | — |
Submission & procedure
- Procedure
- Negotiated without publication of a contract notice
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—
Awarded to